ITEM TITLE:
Pursuant to Section 307B.4, Title 25, Oklahoma Statutes, consider convening in executive session to discuss an action relating to litigation against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused public nuisance and monetary damages suffered by municipalities, specifically, the City's pending litigation in City of Lawton v. Purdue Pharma Inc., et al, CIV-19-78 as part of In Re: National Prescription Opiate Litigation MDL No. 2804, to include a discussion and consideration for approval a potential settlement with distributors Cardinal Health, McKesson Corporation and AmerisourceBergen Corporation, and if necessary take action in open session that may include the approval of one or more resolutions and/or other documents related to any such settlement.
INITIATOR: John Ratliff, City Attorney
STAFF INFORMATION SOURCE: Timothy Wilson, Deputy City Attorney
BACKGROUND: The City Attorney desires to discuss with the Mayor and Council its ongoing opioid litigation and if necessary, take action in open session. Said discussion will include a discussion and consideration of a potential settlement with distributors Cardinal Health, McKesson Corporation and AmerisourceBergen Corporation. The City Attorney advises the City Council that the Council should determine that disclosure of confidential communication between the Council and the City Attorney regarding the above referenced action will seriously impair the ability of the City Attorney to protect the City's interest, and from that determination, the Council should convene in executive session to discuss this matter.
EXHIBIT: N/A
KEY ISSUES: N/A
FUNDING SOURCE: N/A
STAFF RECOMMENDED COUNCIL ACTION: Convene in executive session to discuss an action against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused public nuisance and ...
Click here for full text